| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Antonio Victor Campos Coelho | Q47697110 |
| Fulvio Celsi | Q54449613 | ||
| Paola Maura Tricarico | Q56446591 | ||
| Sergio Crovella | Q88485273 | ||
| P2860 | cites work | Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues | Q28373514 |
| Epigenetic mechanisms of drug resistance: drug-induced DNA hypermethylation and drug resistance | Q28378687 | ||
| Safety of pediatric HIV elimination: the growing population of HIV- and antiretroviral-exposed but uninfected infants | Q28538275 | ||
| Epigenetic alterations in the brain associated with HIV-1 infection and methamphetamine dependence | Q28541100 | ||
| Biological effects of short-term or prolonged administration of 9-[2-(phosphonomethoxy)propyl]adenine (tenofovir) to newborn and infant rhesus macaques | Q28775900 | ||
| Surveillance monitoring for safety of in utero antiretroviral therapy exposures: current strategies and challenges | Q30244368 | ||
| Pharmacological considerations on the use of antiretrovirals in pregnancy. | Q38155004 | ||
| Adverse drug reactions associated with antiretroviral therapy during pregnancy | Q38267557 | ||
| HIV-associated Neurocognitive Disorders and Antiretroviral Therapy: Current Concepts and Controversies | Q38444808 | ||
| Efavirenz alters mitochondrial respiratory function in cultured neuron and glial cell lines | Q38880828 | ||
| Involvement of nitric oxide in the mitochondrial action of efavirenz: a differential effect on neurons and glial cells. | Q38925613 | ||
| Human infection by genetically diverse SIVSM-related HIV-2 in west Africa | Q39242650 | ||
| Developmental Assessments in Preterm Children: A Meta-analysis | Q39547021 | ||
| Elevated adiponectin prevents HIV protease inhibitor toxicity and preserves cerebrovascular homeostasis in mice. | Q39970993 | ||
| The qualitative assessment of general movements in preterm, term and young infants--review of the methodology. | Q41702967 | ||
| Genome-wide analysis of chromosomal features repressing human immunodeficiency virus transcription. | Q42755157 | ||
| Purification of oligodendrocyte precursor cells from rat cortices by immunopanning | Q45370793 | ||
| Pharmacokinetics and antiretroviral activity of lamivudine alone or when coadministered with zidovudine in human immunodeficiency virus type 1-infected pregnant women and their offspring | Q45753331 | ||
| Effects of chronic zidovudine administration on CNS function and virus burden after perinatal SIV infection in rhesus monkeys | Q45783844 | ||
| Zidovudine treatment prolongs survival and decreases virus load in the central nervous system of rhesus macaques infected perinatally with simian immunodeficiency virus | Q45784958 | ||
| Reduced lopinavir exposure during pregnancy | Q46112061 | ||
| Generation and isolation of oligodendrocyte progenitor cells from human pluripotent stem cells | Q48163616 | ||
| The rhesus macaque pediatric SIV infection model - a valuable tool in understanding infant HIV-1 pathogenesis and for designing pediatric HIV-1 prevention strategies | Q30374404 | ||
| Neonatal hippocampal Tat injections: developmental effects on prepulse inhibition (PPI) of the auditory startle response. | Q30437301 | ||
| Neonatal intrahippocampal injection of the HIV-1 proteins gp120 and Tat: differential effects on behavior and the relationship to stereological hippocampal measures | Q30486458 | ||
| Multiple blocks to human immunodeficiency virus type 1 replication in rodent cells | Q33603453 | ||
| An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction | Q33930664 | ||
| Reduction of pyramidal and immature hippocampal neurons in pediatric simian immunodeficiency virus infection | Q34028721 | ||
| HIV-associated neurocognitive disorder: pathogenesis and therapeutic opportunities | Q34037622 | ||
| Early antiretroviral therapy improves neurodevelopmental outcomes in infants | Q34093261 | ||
| Neurodevelopment and in utero antiretroviral exposure of HIV-exposed uninfected infants | Q34181048 | ||
| Progressive mitochondrial compromise in brains and livers of primates exposed in utero to nucleoside reverse transcriptase inhibitors (NRTIs) | Q34200645 | ||
| Neurodevelopment in children born to HIV-infected mothers by infection and treatment status | Q34309494 | ||
| Effects of antiretroviral drugs on human immunodeficiency virus type 1-induced CD4(+) T-cell death. | Q34340138 | ||
| Metabolic and neurologic consequences of chronic lopinavir/ritonavir administration to C57BL/6 mice | Q34349192 | ||
| Efavirenz induces neuronal autophagy and mitochondrial alterations. | Q34360731 | ||
| Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy | Q34387805 | ||
| Safety of efavirenz in the first trimester of pregnancy: an updated systematic review and meta-analysis. | Q34420923 | ||
| Protecting the fetus against HIV infection: a systematic review of placental transfer of antiretrovirals | Q34429204 | ||
| Early identification and intervention in cerebral palsy | Q34429841 | ||
| Congenital anomalies and in utero antiretroviral exposure in human immunodeficiency virus-exposed uninfected infants | Q34860149 | ||
| Cardiac effects of in-utero exposure to antiretroviral therapy in HIV-uninfected children born to HIV-infected mothers | Q34881120 | ||
| IFN-gamma mediates enhancement of HIV replication in astrocytes by inducing an antagonist of the beta-catenin pathway (DKK1) in a STAT 3-dependent manner. | Q35196646 | ||
| Of mice and monkeys: can animal models be utilized to study neurological consequences of pediatric HIV-1 infection? | Q35984276 | ||
| Altered Oligodendrocyte Maturation and Myelin Maintenance: The Role of Antiretrovirals in HIV-Associated Neurocognitive Disorders | Q36169735 | ||
| Standardized mean differences in individually-randomized and cluster-randomized trials, with applications to meta-analysis | Q36309911 | ||
| In-utero triple antiretroviral exposure associated with decreased growth among HIV-exposed uninfected infants in Botswana | Q36389125 | ||
| Antiretroviral exposure during pregnancy and adverse outcomes in HIV-exposed uninfected infants and children using a trigger-based design | Q36438846 | ||
| Antiretroviral neurotoxicity | Q36635673 | ||
| In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children | Q36800856 | ||
| Pharmacokinetics of tenofovir during pregnancy and postpartum | Q36888597 | ||
| Safety of perinatal exposure to antiretroviral medications: developmental outcomes in infants | Q37045192 | ||
| Evaluation of risk for late language emergence after in utero antiretroviral drug exposure in HIV-exposed uninfected infants | Q37202019 | ||
| Antiretroviral drugs induce oxidative stress and neuronal damage in the central nervous system | Q37592018 | ||
| Neuronal toxicity of efavirenz: a systematic review | Q38124394 | ||
| A reliable in vitro model for studying peripheral nerve myelination in mouse. | Q50484908 | ||
| Cognitive and language outcomes in HIV-uninfected infants exposed to combined antiretroviral therapy in utero and through extended breast-feeding. | Q50634718 | ||
| Insulin resistance is associated with cognition among HIV-1-infected patients: the Hawaii Aging With HIV cohort. | Q51910225 | ||
| A prospective controlled study of neurodevelopment in HIV-uninfected children exposed to combination antiretroviral drugs in pregnancy. | Q51913189 | ||
| Concurrent and predictive validity of the cognitive adaptive test/clinical linguistic and auditory milestone scale (CAT/CLAMS) and the Mental Developmental Index of the Bayley Scales of Infant Development. | Q51947771 | ||
| Cognitive and motor deficits associated with HIV-2(287) infection in infant pigtailed macaques: a nonhuman primate model of pediatric neuro-AIDS. | Q52053522 | ||
| Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams. | Q52180229 | ||
| Pharmacokinetic disposition of zidovudine during pregnancy | Q68184172 | ||
| Qualitative changes of spontaneous movements in fetus and preterm infant are a marker of neurological dysfunction | Q68624009 | ||
| Long-term mitochondrial toxicity in HIV-uninfected infants born to HIV-infected mothers | Q73497224 | ||
| Altered heterochromatin organization after perinatal exposure to zidovudine | Q80338690 | ||
| Mitochondrial dysfunction in AIDS and its treatment | Q81110778 | ||
| [A prospective study of neurodevelopment of uninfected children born to human immunodeficiency virus type 1 positive mothers] | Q83485988 | ||
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | human immunodeficiency virus infectious disease | Q18556697 |
| HIV type 1 | Q18907320 | ||
| anti-HIV agents | Q50377208 | ||
| prenatal exposure delayed effects | Q54911376 | ||
| maternal exposure | Q67002819 | ||
| antiretroviral therapy | Q114595933 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P577 | publication date | 2017-02-15 | |
| P1433 | published in | International Journal of Molecular Sciences | Q3153277 |
| P1476 | title | Antiretroviral Treatment in HIV-1-Positive Mothers: Neurological Implications in Virus-Free Children | |
| P478 | volume | 18 |
| Q59351718 | Leukocyte Telomere Length at Birth and During the Early Life of Children Exposed to but Uninfected With HIV After In Utero Exposure to Antiretrovirals |
| Q90277290 | Pediatric Neurodevelopmental Functioning After In Utero Exposure to Triple-NRTI vs. Dual-NRTI + PI ART in a Randomized Trial, Botswana |
Search more.